APIs and Excipients

Croda Completes Global EXCiPACT Accreditation

May 08, 2017

The company is the first multi-site excipient supplier to achieve accreditation across production facilities.

Catalysis, Flow Chemistry Impact API Manufacturing

May 02, 2017

Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.

Understanding How Excipients Affect Drug Quality

April 18, 2017

Equipment and Processing Report

In implementing quality by design for drug formulation, it is crucial to identify the critical properties of excipients and understand how their variation affects the final drug product.

Cobra Biologics Expands Gene Therapy Manufacturing Operations

April 18, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Cobra will increase capacity in response to customer demand for DNA and viral vector production.

Redefining Excipients for Advanced Therapies

April 02, 2017

As regulators strive for balance in cGMPs for cell, gene, and tissue therapies, risk-management principles must guide decisions involving process media and additives.

PAT for Continuous API Manufacturing Progresses

April 02, 2017

Advances in process analytical technology have been achieved, but significant challenges remain.

Characterization of Polymeric Excipients

April 01, 2017

This article summarizes the evolution of the viscosity standards and their corresponding applications in the USP−NF compendia.

Wet Granulation Resolves Tablet Reformulation Challenges

April 01, 2017

A case study reviews the reformulation and scale up of high drug load prototype using wet granulation process for a model formulation.

RSSL Expands Particle Characterization Capabilities

March 28, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

RSSL has added new equipment for measuring the surface area of powder particles, which is important for determining the performance of excipients and APIs.

JRS Pharma Adds Povidone Product Line

March 17, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Excipient manufacturer adds three tablet binding and disintegration products.